News blog

Medical Marketing International

  • BY: Andrew Hore |
  • POSTED: 13/08/2009 |

Medical Marketing International says that if it does not receive an offer of additional funding by 4 September it will be unlikely to continue in operation.

Shares in the cancer treatments developer were suspended at 2.30pm on 13 August 2009 at 3.75p each, which values MMI at £2.39m. The shares have lost three-quarters of their value over the past year.

MMI has found it difficult to raise money because former executive chairman David Best is pursuing a claim relating to his termination of employment. Attempts have been made by MMI to settle this but they were not successful.

Major shareholders have indicated that they are willing to make cash available but no firm proposal has been made.

© 2024 Aim Micro. All rights reserved. This material may not be published, broadcast, rewritten or redistributed.

Browse by issue
All issues
Popular tags
All tags

betbrokers, financial, gold, health, leisure, media, mobile, resources, services, technology

AIM Micro feeds

Keep up to date with articles published at AIMMicro.com. Subscribe to AIM Micro RSS Feeds